enGene Therapeutics Inc. (ENGN) Market Cap
- 2026-09-03: Market Cap $121.92M.
- 2026-06-09: Market Cap $111.87M.
- 2026-04-30: Market Cap $487.01M.
- 2026-03-03: Market Cap $647.12M.
Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.
- Available history
- 2022-10-31 to 2026-09-03
- Data captured
Historical Market Cap
| Date | Market Cap |
|---|
| 2026-09-03 | $121.92M |
|---|
| 2026-06-09 | $111.87M |
|---|
| 2026-04-30 | $487.01M |
|---|
| 2026-03-03 | $647.12M |
|---|
| 2026-01-31 | $638.41M |
|---|
| 2025-12-18 | $547.26M |
|---|
| 2025-10-31 | $375.05M |
|---|
| 2025-09-10 | $322M |
|---|
| 2025-07-31 | $193.69M |
|---|
| 2025-06-09 | $171.2M |
|---|
| 2025-04-30 | $211.43M |
|---|
| 2025-03-05 | $288.02M |
|---|
| 2025-01-31 | $341.55M |
|---|
| 2024-12-16 | $321.15M |
|---|
| 2024-10-31 | $451.14M |
|---|
| 2024-09-06 | $292.26M |
|---|
| 2024-07-31 | $420.05M |
|---|
| 2024-06-11 | $386.01M |
|---|
| 2024-04-30 | $702.12M |
|---|
| 2024-03-07 | $696.87M |
|---|
| 2024-01-31 | $181.87M |
|---|
| 2024-01-25 | $176.3M |
|---|
| 2023-10-31 | $503.28M |
|---|
| 2022-10-31 | $6.76M |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
|---|
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
|---|
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
|---|
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
|---|
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
|---|